Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
5 Results for "
GSK4532990
" in MedChemExpress (MCE) Product Catalog:
Products (5)
5 Results for "GSK4532990" in MCE Product Catalog:
Cat. No.: HY-177634
CAS No.: 2409783-34-0
Synonyms: GSK4532990; ARO-HSD
Target:
Research Areas:
Gatuzosiran (GSK4532990; ARO-HSD) is a GalNAc-conjugated siRNA that inhibits HSD17B13. Gatuzosiran downregulates HSD17B13 mRNA and protein levels. Gatuzosiran improves noninvasive biomarkers of liver function enzymes, liver fibrosis, and steatosis associated with metabolic dysfunction-associated steatohepatitis. Gatuzosiran can be used for research on metabolic dysfunction-associated steatohepatitis .
Cat. No.: HY-177634A
Synonyms: GSK4532990 sodium; ARO-HSD sodium
Target:
Research Areas:
Gatuzosiran sodium (GSK4532990 sodium; ARO-HSD sodium) is a GalNAc-conjugated siRNA that inhibits HSD17B13. Gatuzosiran sodium downregulates HSD17B13 mRNA and protein levels. Gatuzosiran sodium improves noninvasive biomarkers of liver function enzymes, liver fibrosis, and steatosis associated with metabolic dysfunction-associated steatohepatitis. Gatuzosiran sodium can be used for research on metabolic dysfunction-associated steatohepatitis .
Cat. No.: HY-177634B
Target:
Research Areas:
Gatuzosiran sodium scrambled negative control is the sequence scrambled negative control of Gatuzosiran sodium (HY-177634A). Gatuzosiran sodium (GSK4532990 sodium; ARO-HSD sodium) is a GalNAc-conjugated siRNA that inhibits HSD17B13. Gatuzosiran sodium downregulates HSD17B13 mRNA and protein levels. Gatuzosiran sodium improves noninvasive biomarkers of liver function enzymes, liver fibrosis, and steatosis associated with metabolic dysfunction-associated steatohepatitis. Gatuzosiran sodium can be used for research on metabolic dysfunction-associated steatohepatitis .
Cat. No.: HY-177634C
Research Areas:
FAM labled Gatuzosiran sodiumis a FAM labled Gatuzosiran sodium (HY-177634A). Gatuzosiran sodium (GSK4532990 sodium; ARO-HSD sodium) is a GalNAc-conjugated siRNA that inhibits HSD17B13. Gatuzosiran sodium downregulates HSD17B13 mRNA and protein levels. Gatuzosiran sodium improves noninvasive biomarkers of liver function enzymes, liver fibrosis, and steatosis associated with metabolic dysfunction-associated steatohepatitis. Gatuzosiran sodium can be used for research on metabolic dysfunction-associated steatohepatitis .
Cat. No.: HY-177634D
Research Areas:
Cy3 labled Gatuzosiran sodiumis a Cy3 (HY-D0822) labled Gatuzosiran sodium (HY-177634A). Gatuzosiran sodium (GSK4532990 sodium; ARO-HSD sodium) is a GalNAc-conjugated siRNA that inhibits HSD17B13. Gatuzosiran sodium downregulates HSD17B13 mRNA and protein levels. Gatuzosiran sodium improves noninvasive biomarkers of liver function enzymes, liver fibrosis, and steatosis associated with metabolic dysfunction-associated steatohepatitis. Gatuzosiran sodium can be used for research on metabolic dysfunction-associated steatohepatitis .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
